盧喜 鄭軍霞 劉曉梅 張瑾熔
Th 17/Treg、IL-17在近交系BALB/C小鼠大腸癌肝轉(zhuǎn)移模型中表達(dá)及意義
盧喜1鄭軍霞2劉曉梅1張瑾熔1
目的 研究Th 17/Treg、IL-17在近交系BALB/C小鼠大腸癌肝轉(zhuǎn)移模型中的表達(dá)及意義。方法 采用近交系BALB/C小鼠脾內(nèi)種植法建立大腸癌肝轉(zhuǎn)移模型,用免疫組化方法檢測(cè)肝轉(zhuǎn)移瘤及血清中IL-17、Treg細(xì)胞和Th 17細(xì)胞的分布,比較其在肝轉(zhuǎn)移初期和晚期的差別。結(jié)果 晚期結(jié)腸癌肝轉(zhuǎn)移瘤組織中Th 17低于早期肝轉(zhuǎn)移瘤,P<0.05,差異具有統(tǒng)計(jì)學(xué)意義,而IL-17、Treg細(xì)胞在晚期肝轉(zhuǎn)移瘤組織中高于早期,P<0.05,差異具有統(tǒng)計(jì)學(xué)意義。結(jié)論 IL-17、Th 17/Treg細(xì)胞在大腸癌肝轉(zhuǎn)移瘤中的表達(dá),可能對(duì)評(píng)估病情進(jìn)展有一定意義。且早期肝轉(zhuǎn)移瘤中Th 17細(xì)胞增高,并具有抗腫瘤活性,這可能是大腸癌免疫治療的新策略。
Th 17;Treg;大腸癌;肝轉(zhuǎn)移
大腸癌是常見(jiàn)的消化道腫瘤之一,肝轉(zhuǎn)移為主要死因。IL-17、Treg細(xì)胞和Th 17細(xì)胞作為新發(fā)現(xiàn)的具有獨(dú)立調(diào)節(jié)機(jī)制的免疫細(xì)胞,其在轉(zhuǎn)移瘤中的表達(dá)及意義在國(guó)內(nèi)未見(jiàn)報(bào)道。通過(guò)建立BALB/C小鼠結(jié)腸癌肝轉(zhuǎn)移模型,比較大腸癌肝轉(zhuǎn)移瘤組織中IL-17、Treg細(xì)胞和Th 17細(xì)胞的表達(dá),為大腸癌肝轉(zhuǎn)移的發(fā)生發(fā)展提供更多的研究證據(jù)。
1.1 材料
將80只采用脾內(nèi)種植法制備近交系BALB/C小鼠脾內(nèi)種植小鼠結(jié)腸癌細(xì)胞株的大腸癌肝轉(zhuǎn)移模型小鼠隨機(jī)分為兩組,另取20只健康BALB/C小鼠為空白組,第1組于第16天處死,第2組及空白組于第23天處死。所有小鼠均于處死后取轉(zhuǎn)移瘤及血清標(biāo)本,用免疫組化方法檢測(cè)與肝轉(zhuǎn)移癌IL-17、Treg細(xì)胞和Th 17細(xì)胞的表達(dá)。
1.2 統(tǒng)計(jì)學(xué)方法
2.1 兩組小鼠外周血中Th 17、Treg及Treg/Th 17的細(xì)胞水平
出現(xiàn)肝轉(zhuǎn)移小鼠血清中Treg細(xì)胞、及Treg/Th 17的水平高于對(duì)照組,P<0.05,差異具有統(tǒng)計(jì)學(xué)意義,Th 17細(xì)胞水平低于對(duì)照組,P<0.05,差異具有統(tǒng)計(jì)學(xué)意義。Th l7 陽(yáng)性細(xì)胞數(shù)在小鼠外周血中低空白組,且在23天組中的表達(dá)低于16天組。見(jiàn)表1。
2.2 兩組肝轉(zhuǎn)移瘤中Th 17細(xì)胞、IL-17、Treg細(xì)胞水平與對(duì)照組比較
IL-17、Treg細(xì)胞水平在小鼠大腸癌肝轉(zhuǎn)移腫瘤組織中高于空白組,P<0.05,差異具有統(tǒng)計(jì)學(xué)意義,且與肝轉(zhuǎn)移瘤進(jìn)展呈正相關(guān)。Th 17細(xì)胞水平在肝轉(zhuǎn)移瘤組的表達(dá)低于空白組。
免疫微環(huán)境與腫瘤的關(guān)系密切,機(jī)體依賴體內(nèi)T細(xì)胞對(duì)抗腫瘤細(xì)胞。Th l7細(xì)胞是一種新發(fā)現(xiàn)的輔助性T細(xì)胞亞群,分化發(fā)育機(jī)制獨(dú)特,可分泌相關(guān)細(xì)胞因子IL-17、IL-21等。在腫瘤的發(fā)生發(fā)展中發(fā)揮重要的作用。Kryczek 等[1]發(fā)現(xiàn)Th l7細(xì)胞具有抗腫瘤效應(yīng),而與腫瘤浸潤(rùn)的Treg細(xì)胞負(fù)相關(guān)。Chen等[2]發(fā)現(xiàn)IL-17存在于肺癌組織中,在晚期患者組織中的表達(dá)更高。研究發(fā)現(xiàn)[3]IL-17主要起到促進(jìn)腫瘤生長(zhǎng)作用。本次研究結(jié)果表明,Th l7細(xì)胞在結(jié)腸癌肝轉(zhuǎn)移微環(huán)境中的聚集發(fā)生在腫瘤的早期階段,隨著病程進(jìn)展,Th l7細(xì)胞的聚集程度逐步降低;IL-17的細(xì)胞水平與肝轉(zhuǎn)移瘤進(jìn)展呈正相關(guān)。Treg細(xì)胞在人類(lèi)腫瘤微環(huán)境中數(shù)量增多,發(fā)揮著一定的促進(jìn)腫瘤生長(zhǎng)的作用。小鼠實(shí)驗(yàn)?zāi)P椭邪l(fā)現(xiàn)Treg細(xì)胞可抑制腫瘤浸潤(rùn)的淋巴結(jié)及外周血效應(yīng)T細(xì)胞群的免疫應(yīng)答。通過(guò)抗體抑制Treg細(xì)胞的表面分子來(lái)抑制Treg的功能或數(shù)目能夠增強(qiáng)機(jī)體抗腫瘤活性,進(jìn)一步證明了Treg在腫瘤免疫系統(tǒng)中的負(fù)向調(diào)節(jié)作用??煽紤]從免疫治療的角度控制腫瘤的進(jìn)展,負(fù)向調(diào)節(jié)Treg細(xì)胞是非常重要的治療靶點(diǎn)。
表1 第1組及第2組小鼠外周血中Th 17、Treg及Treg/Th 17的細(xì)胞水平
表2 第1、2組肝轉(zhuǎn)移瘤中Th 17細(xì)胞、IL-17、Treg細(xì)胞水平與對(duì)照組比較
總之,本研究通過(guò)免疫組織化學(xué)方法證實(shí)了Treg細(xì)胞、IL-17在大腸癌肝轉(zhuǎn)移瘤中表達(dá)增加,且與肝轉(zhuǎn)移瘤進(jìn)展呈正相關(guān),這可能對(duì)評(píng)估病情進(jìn)展有一定意義。且早期肝轉(zhuǎn)移瘤中Th 17細(xì)胞增高,并具有抗腫瘤活性,這可能是大腸癌免疫治療的新策略。
[1]Kryczek I,Banerjee M,Cheng P,et al.Phenotype distribution,generation and functional and clinical relevance of Thl7cells in the human tumor environments[J].Blood,2009,114(6):1141-1149.
[2]Chen X,Wan J,Liu J,et al.Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients[J].Lung Cancer,2010,69(3):348-354.
[3]魏文,李娟娟,孫圣榮,等.乳腺癌小鼠動(dòng)物模型中白細(xì)胞介素-17的表達(dá)及其意義[J].中華實(shí)驗(yàn)外科雜志,2011,28(5):673-675.
The Expression and Significance of Th 17/Treg and IL-17 in Model of Liver Metastasis of Colorectal Cancer in BALB/C Mice
LU Xi1ZHENG Junxia2LIU Xiaomei1ZHANG Jinrong11 The Affiliated Tumor Hospital Department of Radiotherapy of Xinjiang Medical University,Urumqi 830054,China.2 The Affiliated Tumor Hospital The First District of Palliative Treatment Department of Xinjiang Medical University,Urumqi 830054,China
Objective To study the Th 17/Tregm and IL-17 expression and significance in inbred BALB/C mice with colorectal cancer liver metastasis model.Methods The method of planting inbred strains of cancer cells within the BALB/C mouse spleen established colorectal liver metastases model using immunohistochemical method to detect the distribution of IL-17,Treg cell and Th 17 cells in colorectal liver metastases and normal liver tissue,compared the difference in the early and late liver metastasis.Results Th 17 in advanced colorectal cancer liver metastases tissue was significantly lower than early liver metastases,P<0.05,had difference statistically significance.IL-17 and Treg in advanced colorectal cancer liver metastases tissue was significantly higher than liver metastases,P<0.05,had difference statistically significance.Conclusion The expression of IL-17 and Th 17/Treg cells in the liver metastasis of colorectal carcinoma may have some significance meaning.Th 17 was increased in the early stage of liver metastasis,and it has anti-tumor activity,which may be a new strategy for the treatment of colorectal cancer.
Th 17,Treg,Colorectal Cancer,Liver metastasis
R735.3+4
B
1674-9308(2015)29-0030-02
10.3969/j.issn.1674-9308.2015.29.021
1830054烏魯木齊,新疆醫(yī)科大學(xué)附屬腫瘤醫(yī)院胸腹放療科;2830054烏魯木齊,新疆醫(yī)科大學(xué)附屬腫瘤醫(yī)院姑息治療一病區(qū)
新疆醫(yī)科大學(xué)科研創(chuàng)新基金項(xiàng)目(項(xiàng)目編號(hào):XJC2013101)
張瑾熔,E-mail:16428614@qq.com